Both High and Low Levels of Vitamin D Found in Heart Deaths


Vitamin D levels that are either very low or very high are associated with cardiovascular death rates, a Danish study found. The question is whether than relationship is causal or just an association.

Too much vitamin D may be just as bad as too little, a Danish study found.

Writing in the Journal of Clinical Endocrinology and Metabolism, Peter Schwarz, MD, of the University of Copenhagen’s department of clinical medicine, and colleagues reported on deaths in a cohort of nearly 247,574 patients. The team first identified that cohort, then in a 7-year follow-up, looked at data on 16,645 of those subjects who died during the study period. Their causes of death were recorded in the Danish Registry of Causes of Death.

Because there was data available on 25-hydroxyvitamin D levels in all patients in the cohort, they were able to assess how those levels correlated with various causes of death.

In the 16,645 patients who died, 5,454 died of cardiovascular disease.

The researchers found that both low and high levels of vitamin D were associated with cardiovascular disease, stroke, and acute myocardial mortality.

But they could not rule out the possibility that the vitamin levels were merely an association rather than a causal factor. For instance, other studies have suggested that a gene that affects vitamin D status could also play a role in determining cardiovascular risk factors.

“There is a need for randomized clinical trials which include information on the effects of 25-hydroxyviamin D levels above 100 nmol/L,” Schwarz concluded.

The lowest incidence of cardiovascular deaths was seen in deceased patients whose vitamin D level when originally assessed was 70 nmol/L. But cardiovascular death rates were higher in patients with a low vitamin D level, defined as 12.5 nmol/L (the hazard ratio was 2.0 overall and 2.5 for men) and in those with a high (that is, 125 nmol/L) level of vitamin D (the hazard ratio was 1.3).

The hazard ratios applied equally to cardiovascular, stroke, and acute myocardial infarct mortality.

Related Videos
Video 2 - "Lessons from EXPLORER-HCM: Unveiling CMIs' Potential in oHCM Treatment "
Video 1 - "Novel Cardio Myosin Inhibitors Targeting Obstructive Hypertrophic Cardiomyopathy's Root Cause "
A panel of 5 cardiovascular experts
A panel of 5 cardiovascular experts
Heart Failure Treatment Outcomes and Contraindications
Getting Black Men Involved in Their Health Care, Clinical Research
Patient Involvement in Advanced HF Treatment, with Ashley Malliett, DMSc, MPAS, PA-C
Aaron Henry, PA-C, MSHS: Regaining Black Male Patient Trust in the Doctor's Office
Tailoring Chest Pain Diagnostics to Patients, with Kyle Fortman, PA-C, MBA
Kyle Fortman, PA-C, MBA: Troponin and Heart Injury Risk Screening Recommendations
© 2024 MJH Life Sciences

All rights reserved.